Subsequent survival analyses confirmed that overexpression of MYBL2 outperformed both E2F1 and FOXM1 transcription factors in identifying lung adenocarcinoma patients with poor outcomes (Figure 2, Figure S1). The gene discussed is MYBL2; the disease is lung adenocarcinoma.